Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes

Abstract Background Atherosclerotic cardiovascular diseases (CVD) is the leading cause of death in diabetes, but the full range of biomarkers reflecting atherosclerotic burden and CVD risk in people with diabetes is unknown. Metabolomics may help identify novel biomarkers potentially involved in dev...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Zhe Huang, Lucija Klaric, Justina Krasauskaite, Stela McLachlan, Mark W. J. Strachan, James F. Wilson, Jackie F. Price
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2022-04-01
coleção:	Cardiovascular Diabetology
Assuntos:	Atherosclerosis Cardiovascular diseases Glycolysis Lactate Lipidomics Metabolomics
Acesso em linha:	https://doi.org/10.1186/s12933-022-01493-w
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!